101 - Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy

Presenting Author(s)

• 

  Shawnalyn Sunagawa, PharmD (she/her/hers)

  PGY2 Infectious Diseases Pharmacy Resident
  Nebraska Medicine
  Omaha, NE, United States

  Slides

Co-Author(s)

• SA

  Sarah Arduser, BS, PharmD Candidate

  Pharmacy Student
  Nebraska Medicine
  Omaha, Nebraska, United States
• 

  Molly M. Miller, PharmD, BCIDP

  Clinical Pharmacist Practitioner
  Nebraska Medicine
  Omaha, Nebraska, United States
• EL

  Elizabeth Lyden, MS

  Associate Director, Center for Collaboration on Research, Design and Analysis
  University of Nebraska Medical Center
  Omaha, Nebraska, United States
• 

  Nicolas W. Cortes-Penfield, MD (he/him/his)

  Assistant Professor Medical Director, Outpatient Parenteral Antimicrobial Therapy Program
  University of Nebraska Medical Center
  Omaha, NE, United States
• RH

  Richard Hankins, MD

  Assistant Professor in Infectious Diseases
  Nebraska Medicine
  Omaha, Nebraska, United States
• 

  Scott J. Bergman, PharmD

  Pharmacy Coordinator
  Nebraska Medicine
  Omaha, Nebraska, United States
• 

  Bryan T. Alexander, PharmD, BCIDP, AAHIVP

  Pharmacy Coordinator
  Nebraska Medicine
  Omaha, Nebraska, United States